Glancy Prongay Drops Out Of Blood Drug Lead Counsel Race

By Ryan Harroff · March 21, 2023, 4:44 PM EDT

Glancy Prongay & Murray withdrew its bid to serve as lead counsel in a proposed class action brought against an Israeli biotech company accused of misleading its investors, stating that after...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE BIOLINERX LTD. SECURITIES LITIGATION

Case Number

2:23-cv-00041

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

January 05, 2023